To study cellular changes driving interstitial lung disease (ILD), normal human PCLuS without ILD, were challenged with a cocktail of pro-fibrogenic and pro-inflammatory factors; TGFβ, TNFα, PDGFAB, and lysophosphatidic acid [36]. This evidence concerns the gene TGFB1 and interstitial lung disease.